Hind Rafei
@hindrafei
Physician-scientist at MD Anderson Cancer Center investigating cellular immunotherapy for solid cancers with a focus on the solid TME. Opinions are my own.
ID: 1732651651
05-09-2013 17:52:48
1,1K Tweet
2,2K Followers
3,3K Following
Eric Vivier Innate Pharma Miriam Merad, MD, PhD Speakers presenting their vision of the future of immunotherapy include Tom Marron MD PHD Katy Rezvani, M.D., Ph.D E. John Wherry, Diane Mathis and more in two sessions chaired by Joao Monteiro and Horowitz Lab @Icahn School of Medicine Mount Sinai.
From Luciane T Kagohara 🇧🇷🧬👩🏻🔬👩🏻💻 Ashley Kiemen Denis Wirtz & colleagues Johns Hopkins Kimmel Cancer Center PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration sciencedirect.com/science/articl… Spatial transcriptomics of archival #PancreaticCancer precursor lesions, with validation
Delighted to share our latest research published in Cancer Cell Cell. Our study shows that intratumoral administration of IL-21 engineered NK cells resulted in strong and sustained antitumor activity against glioblastoma compared to IL-15 NK cells, which carried significant
Congratulations to Mayra Shanley and Katy Rezvani, M.D., Ph.D team for this beautiful story just published in @Canc_Cell of IL-21 engineered NK cells for cell therapy of glioblastoma! Very excited about the clinical translation ahead! The future is bright for NK cell therapy ❤️🎊🎉!#NK #GBM
Engineering NK cells with IL-21 for cellular therapy of glioblastoma - Mayra Shanley Katy Rezvani, M.D., Ph.D May Daher Hind Rafei Merve Dede Dr. Elizabeth Shpall oncodaily.com/insight/124241 #Cancer #Glioblastoma #BrainCancer #CancerResearch #OncoDaily #Oncology
Oncoinfluencers to Follow on Social Media: Dr. Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center oncodaily.com/blog/126866 #Cancer #MedOnc #Oncologist #OncoDaily #Oncology
Congratulations May Daher Bijender Kumar Katy Rezvani, M.D., Ph.D and team for this beautiful story and all the translations that could come out of it for AML with NK and CAR NK cell therapy! 🎊🎉 MD Anderson Cancer Center #NK #AML
Our Dr. Katy Rezvani presented her latest research on CAR NK cells at #ESMO24. See the full schedule for tomorrow's presentations: brnw.ch/21wMGMs ESMO - Eur. Oncology Katy Rezvani, M.D., Ph.D #EndCancer
New online perspective article Cancer Research article timed with the ongoing #PancreaticCancer stroma session at #AACRPan24 Pancreatic Cancer-Associated Fibroblasts: Where do we go from here? A conversation with three experts on the PDAC stroma (Mara Sherman Lab Dr. Edna Cukierman, Ph.D. &
Check out this perspective on PDAC CAFs and their challenges. I had fun writing this with Eileen Carpenter and Marie Hasselluhn, summarizing the opinions of the “CAF trinity”Mara Sherman Lab Dr. Edna Cukierman, Ph.D. PascaLab on those challenges! PDAC Stromal Reprogramming Consortium Anirban Maitra KenOliveLab
Fantastic review by Ruth Shouval lab; regulation of T-cell infiltration and activity in solid tumors by CAFs
It was awesome to host Rafet and sunil acharya from Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center for a talk Dana-Farber today. Hats off to Dr Rezvani’s group for innovating the NK cell therapies. #NK #NKCar #Immunotherapy #Romeelab
It was a true pleasure meeting with you again Rizwan Romee and brainstorming about the future of CAR NK cells. Thank you so much for your hospitality, and I look forward to catching up soon! MD Anderson Cancer Center Dana-Farber sunil acharya #NK #NKCAR
My superstar friend and scientist extraordinaire killing it on the podium with all the cool science and translations of CD70 CAR NK cells! Way to go sunil acharya MD Anderson Cancer Center Katy Rezvani, M.D., Ph.D
Incredibly proud of our superstar PhD student Yu-Sung(Kevin) Hsu for delivering an outstanding talk at the Cancer Biology retreat this afternoon GSBS Immunology Program! Very excited about all the great work he is doing to improve our CAR NK cells in solid tumors Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center
